Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 8/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 8/20 | 0.45 |
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.40 |
| ▸ | CKS1B | P61024 | 2/20 | 0.37 |
| ▸ | SKP1 | P63208 | 2/20 | 0.37 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26645196 | 0.91 | CSNK1D (0.51) | CSNK1DCSNK1EGPR119 | |
| SCHEMBL26645250 | 0.88 | CSNK1D (0.48) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645466 | 0.88 | CSNK1D (0.49) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645019 | 0.87 | CSNK1D (0.47) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645681 | 0.87 | CSNK1E (0.48) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645705 | 0.87 | CSNK1D (0.46) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645399 | 0.87 | CSNK1E (0.46) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645816 | 0.86 | CSNK1D (0.44) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645053 | 0.86 | CSNK1D (0.46) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645342 | 0.85 | CSNK1E (0.45) | CSNK1DCSNK1EGPR119CKS1BSKP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |